Your browser doesn't support javascript.
loading
Clear-cell Renal Cell Carcinoma: Molecular Characterization of IMDC Risk Groups and Sarcomatoid Tumors.
Verbiest, Annelies; Renders, Inne; Caruso, Stefano; Couchy, Gabrielle; Job, Sylvie; Laenen, Annouschka; Verkarre, Virginie; Rioux-Leclercq, Nathalie; Schöffski, Patrick; Vano, Yann; Elaidi, Reza-Thierry; Lerut, Evelyne; Albersen, Maarten; Oudard, Stéphane; Fridman, Wolf-Hervé; Sautès-Fridman, Catherine; Albigès, Laurence; Wozniak, Agnieszka; Zucman-Rossi, Jessica; Beuselinck, Benoit.
Afiliação
  • Verbiest A; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Renders I; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium.
  • Caruso S; Inserm, UMR-1162, Génomique fonctionnelle des tumeurs solides, IUH, Paris, France.
  • Couchy G; Inserm, UMR-1162, Génomique fonctionnelle des tumeurs solides, IUH, Paris, France.
  • Job S; Programme Cartes d'Identité des Tumeurs, Ligue Nationale Contre le Cancer, Paris, France.
  • Laenen A; Biostatistics and Statistical Bioinformatics Center, KU Leuven, Leuven, Belgium.
  • Verkarre V; Department of Pathology, Necker-Enfants Malades University Hospital, AP-HP, Paris, France.
  • Rioux-Leclercq N; Department of Pathology, CHU de Rennes, Rennes, France.
  • Schöffski P; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Vano Y; Department of Medical Oncology, Hôpital Européen Georges Pompidou, AP-HP, Paris, France.
  • Elaidi RT; Department of Medical Oncology, Hôpital Européen Georges Pompidou, AP-HP, Paris, France.
  • Lerut E; Department of Imaging and Pathology, KU Leuven, Leuven, Belgium.
  • Albersen M; Department of Urology, University Hospitals Leuven, Leuven, Belgium.
  • Oudard S; Department of Medical Oncology, Hôpital Européen Georges Pompidou, AP-HP, Paris, France.
  • Fridman WH; Inserm, UMR-S1138, Centre de Recherche des Cordeliers, Sorbonne University, Paris, France.
  • Sautès-Fridman C; Inserm, UMR-S1138, Centre de Recherche des Cordeliers, Sorbonne University, Paris, France.
  • Albigès L; Department of Medical Oncology, Institut Gustave Roussy, Villejuif, France.
  • Wozniak A; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium.
  • Zucman-Rossi J; Inserm, UMR-1162, Génomique fonctionnelle des tumeurs solides, IUH, Paris, France.
  • Beuselinck B; Department of General Medical Oncology, University Hospitals Leuven, Leuven, Belgium; Laboratory of Experimental Oncology, Department of Oncology, KU Leuven, Leuven, Belgium; Inserm, UMR-1162, Génomique fonctionnelle des tumeurs solides, IUH, Paris, France. Electronic address: benoit.beuselinck@uzle
Clin Genitourin Cancer ; 17(5): e981-e994, 2019 10.
Article em En | MEDLINE | ID: mdl-31229459
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Biomarcadores Tumorais / Inibidores da Angiogênese / Neoplasias Renais Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Carcinoma de Células Renais / Biomarcadores Tumorais / Inibidores da Angiogênese / Neoplasias Renais Tipo de estudo: Etiology_studies / Prognostic_studies / Risk_factors_studies Limite: Female / Humans / Male Idioma: En Ano de publicação: 2019 Tipo de documento: Article